Brief: Sio Gene Therapies Announces Fiscal Year 2020 Year-End Financial Results And Expected Fiscal Year 2021 Key Milestones

Sio Gene Therapies

09/06/2021 12:48

June 9 (Reuters) - Sio Gene Therapies Inc  SIOX.O :
    * SIO GENE THERAPIES ANNOUNCES FISCAL YEAR 2020 YEAR-END
FINANCIAL
RESULTS AND EXPECTED FISCAL YEAR 2021 KEY MILESTONES
    * Q4 LOSS PER SHARE $0.05
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.17 -- REFINITIV IBES
DATA
    * SIO GENE THERAPIES - AS OF MARCH 31, 2021, HAD $119.0
MILLION OF
CASH, CASH EQUIVALENTS
    * SIO GENE THERAPIES - ESTIMATE THAT CURRENT CASH, CASH
EQUIVALENTS WILL SUSTAIN OPERATIONS INTO Q4 2022

Source text for Eikon:  ID:nGNX5MVV2m 
Further company coverage:  SIOX.O 

 ((Reuters.Briefs@thomsonreuters.com;))